Singapore approves mpox vaccine from Bavarian Nordic for high-risk adults
Singapore’s Health Sciences Authority (HSA) has approved the JYNNEOS vaccine, developed by Danish pharmaceutical company Bavarian Nordic, for individuals aged 18 and older at high risk for smallpox or mpox. …
Singapore approves mpox vaccine from Bavarian Nordic for high-risk adults Read More